Press release
Geriatric Population Growth As A Key Driver Of The Chronic Disease Management Market: The Driving Engine Behind Chronic Disease Management Market Evolution in 2025
Chronic Disease Management Market
Chronic Disease Management Market Size Growth Forecast: What to Expect by 2025?
The market size of chronic disease management has seen a swift expansion in the past few years. The market is projected to surge from $9.55 billion in 2024 to $11.36 billion in 2025, with a compound annual growth rate (CAGR) of 19.0%. Factors like the application of data analytics in population health management, patient learning initiatives, the implementation of value-based healthcare models, personalized treatment methodologies, and a strong focus on preventive healthcare, have fueled the growth during this historic period.
How Will the Chronic Disease Management Market Size Evolve and Grow by 2029?
The market for managing chronic diseases is anticipated to witness significant expansion in the upcoming years. The projected growth will bring it to a valuation of $24.97 billion by 2029 with a compound annual growth rate (CAGR) of 21.8%. This surge in the predicted period can be credited to the implementation of patient-focused care models, an aging global population, the rise in remote patient monitoring (rpm), an increased incidence of chronic diseases, and worldwide healthcare tendencies. The forecast period is marked by key trends such as responding to global health crises and pandemics, government-driven initiatives and policy backing, the development of consumer health applications and platforms, advancing health information exchanges and interoperability, an emphasis on behavioral health, and the broadening scope of telehealth.
View the full report here:
https://www.thebusinessresearchcompany.com/report/chronic-disease-management-global-market-report
What Drivers Are Propelling the Growth of Chronic Disease Management Market Forward?
The escalating number of elderly people, notably those above 65 years of age, is triggering the expansion of the chronic disease management market significantly. The possibility of this age group enduring chronic diseases is remarkably high. These chronic ailments often necessitate an influx of further medical attention and on-going care support, thereby amplifying the demand for chronic disease management solutions. For example, a World Health Organization (WHO) report issued in October 2024, the WHO being a Swiss agency devoted to global health matters, anticipated that by 2030, one out of every six people worldwide would be 60 or older. By 2050, the global population of individuals 60 and above is expected to surge to 2.1 billion. Thus, the burgeoning geriatric population is anticipated to stimulate the expansion of the chronic disease management market.
Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=6984&type=smp
Which Emerging Trends Are Transforming the Chronic Disease Management Market in 2025?
The uptake of technological innovation is an emerging trend seen in the chronic disease management sector. Cutting-edge technologies, for example, artificial intelligence (AI), are being integrated into treatment modalities for chronic diseases. This allows healthcare professionals to make breakthroughs in early detection and improve patient results for conditions such as heart disease, cancer, and diabetes. As an example, Biofourmis, a startup from Boston that specializes in AI-based virtual healthcare and digital therapeutics, unveiled Biofourmis Care in February 2022. This is a service dedicated to offering high-quality remote healthcare to individuals battling chronic illnesses. The primary focus of Biofourmis Care is to enhance the adherence of providers to care-guidelines and identify clinical decay patterns to enable timely treatments.
What Are the Key Segments in the Chronic Disease Management Market?
The chronic disease management market covered in this report is segmented -
1) By Service: Consulting Service, Implementation Service, Educational Service
2) By Delivery Mode: On-premise, Cloud-based, Web-based
3) By Disease Type: Cardiovascular Diseases, Diabetes, Cancer, Asthma, Chronic Obstructive Pulmonary Disorders
4) By End User: Providers, Payers
Subsegments:
1) By Consulting Service: Disease Management Assessment, Program Design And Development, Performance Evaluation
2) By Implementation Service: Technology Integration, Workflow Optimization, Care Coordination
3) By Educational Service: Patient Education Programs, Provider Training, Community Awareness Initiatives
Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=6984&type=smp
Who Are the Key Players Shaping the Chronic Disease Management Market's Competitive Landscape?
Major companies operating in the chronic disease management market include Allscripts Healthcare Solutions Inc. (now known as Veradigm Inc. ), ScienceSoft USA Corporation, Siemens Healthcare Private Limited, Infosys Limited, MINES and Associates Inc., Biofourmis Care Solutions Pte. Ltd., i2i Systems Inc., Phytel Inc., Wellcentive Inc., TriZetto Corporation, Mediware Human & Social Services Inc., Pegasystems Inc., ZeOmega Inc., Cigniti Technologies Limited, Health Catalyst, Cedar Gate Technologies, Epic Systems Corporation, Hinduja Global Solutions Ltd., NXGN Management LLC, Casenet LLC, ExlServings Holdings Inc., cliexa Inc., Vivify Health Inc., WellSky, Alkeus Pharmaceuticals, Healthy. io, Immunic Inc., GlaxoSmithKline (GSK), GEOVAX INC., Bluebird Bio, Optum Inc., Omada Health
What Geographic Markets Are Powering Growth in the Chronic Disease Management Market?
North America was the largest region in the chronic disease management market in 2024.Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the chronic disease management market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6984
This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.
Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.
Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info
Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Geriatric Population Growth As A Key Driver Of The Chronic Disease Management Market: The Driving Engine Behind Chronic Disease Management Market Evolution in 2025 here
News-ID: 4075123 • Views: …
More Releases from The Business Research Company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Disease
Protheragen Announces Disease Model Development Services to Enhance Rare Disease …
Protheragen announced the release of its disease model development services provided to enhance rare disease research. With an increasing focus on rare diseases and the need for tailored research models, Protheragen is dedicated to providing cutting-edge solutions to support this important area of medical research.
Rare diseases, which affect a small percentage of the population, pose unique challenges for researchers due to their limited understanding and lack of available treatment options.…
Biopharmaceutical Fermentation Market 2022 | Growing Morbidity of Genetic Diseas …
According to Precision Business Insights (PBI), the latest report, the biopharmaceutical fermentation market is expected to be valued at USD 10,302.1 million in 2022, growing at a 4.7% CAGR from 2022 to 2028. The growing prevalence of chronic illness, cancer, cardiac diseases, infectious diseases, antibiotic resistance, autoimmune diseases, etc., globally causes the leaning toward biopharmaceutical products, which show promising results in the research studies. Moreover, new findings by the…
Global Inflammatory Bowel Disease (IBD) Market Key Players Analysis, Disease Ind …
Global Inflammatory Bowel Disease (IBD) Market, valued at USD 210.5 Billion in the year 2020 has been driven by factors such as the increasing prevalence of Ulcerative Colitis and Crohn’s Disease, advances in medical technology, government support for inflammatory bowel disease treatment research, and the ubiquity of anxiety and depression. Moreover, factors such as the irregular food habits, unhealthy lifestyle of people, increased level of pollution and increase in alcohol…
Moyamoya Disease Market - A Scientometric Assessment of Disease During 2018-23
Market Highlight:
Moyamoya disease (MMD) is a chronic, cerebrovascular disease characterized by progressive stenosis in the internal carotid artery and an abnormal vascular network at the base of the brain. The stroke is one of the significant symptoms of moyamoya disease, which further leads to paralysis of the face, arms, and legs, loss of speech, and temporary loss of neurologic function of body parts, visual disturbances, headaches, developmental delay, and…
Refsum Disease Industry An Overview of A New Disease - 2018
"Refsum Disease" is a genetic disorder which is inherited as an autosomal recessive trait. The condition is characterized by progressive loss of vision (retinitis pigmentosa), failure of muscle coordination (ataxia), degenerative nerve disease (peripheral neuropathy), and dry, rough, scaly skin (ichthyosis). The accumulation of fatty acid (phytanic acid) in blood plasma and tissues is the main cause of refsum disease. This occurs due to malfunction of the enzyme producing gene…
Chagas Disease (Infectious Disease) Pipeline Forecast Report, H1, 2017 [MRH]
Market Research Hub's Pharmaceutical and Healthcare latest pipeline guide Chagas Disease - Pipeline Review, H1 2017, provides comprehensive information on the therapeutics under development for Chagas Disease Market (Infectious Disease), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and…
